Structural characterization of novel phospholipid lipid nanoparticles for controlled drug delivery.

[1]  Sanjun Shi,et al.  Lipid nanoparticles loaded with 10-hydroxycamptothecin–phospholipid complex developed for the treatment of hepatoma in clinical application , 2010, Journal of drug targeting.

[2]  Yan Wang,et al.  Development of a chemically stable 10-hydroxycamptothecin nanosuspensions. , 2009, International journal of pharmaceutics.

[3]  Zhirong Zhang,et al.  [Preparation and characterization of artemether-iron sucrose lipid nanoparticles]. , 2009, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition.

[4]  D. Mcclements,et al.  Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN). , 2009, Journal of colloid and interface science.

[5]  R. Müller,et al.  Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[6]  B. D. Anderson,et al.  Determination of intraliposomal pH and its effect on membrane partitioning and passive loading of a hydrophobic camptothecin, DB-67. , 2008, International journal of pharmaceutics.

[7]  R. Müller,et al.  Cyclosporine-loaded solid lipid nanoparticles (SLN): drug-lipid physicochemical interactions and characterization of drug incorporation. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[8]  A. Attama,et al.  Effect of beeswax modification on the lipid matrix and solid lipid nanoparticle crystallinity , 2008 .

[9]  C. Demetzos,et al.  Scanning electron microscopy study on nanoemulsions and solid lipid nanoparticles containing high amounts of ceramides. , 2007, Micron.

[10]  Baorui Liu,et al.  10-Hydroxycamptothecin loaded nanoparticles: preparation and antitumor activity in mice. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[11]  R. Bittl,et al.  Interaction of drug molecules with carrier systems as studied by parelectric spectroscopy and electron spin resonance. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[12]  M. R. Mozafari.  Nanocarrier Technologies: Frontiers of Nanotherapy , 2006 .

[13]  M. Schubert,et al.  Structural investigations on lipid nanoparticles containing high amounts of lecithin. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[14]  S. Wartewig,et al.  Solid Lipid Nanoparticles (SLN) and Oil-Loaded SLN Studied by Spectrofluorometry and Raman Spectroscopy , 2005, Pharmaceutical Research.

[15]  M. Garcia‐Fuentes,et al.  Design and characterization of a new drug nanocarrier made from solid-liquid lipid mixtures. , 2005, Journal of colloid and interface science.

[16]  Karsten Mäder,et al.  Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[17]  K. Mäder,et al.  Physicochemical Investigations on Solid Lipid Nanoparticles and on Oil-Loaded Solid Lipid Nanoparticles: A Nuclear Magnetic Resonance and Electron Spin Resonance Study , 2003, Pharmaceutical Research.

[18]  J. Kristl,et al.  Interactions of solid lipid nanoparticles with model membranes and leukocytes studied by EPR. , 2003, International journal of pharmaceutics.

[19]  R. Müller,et al.  Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. , 2002, Advanced drug delivery reviews.

[20]  S. Mantripragada.  A lipid based depot (DepoFoam technology) for sustained release drug delivery. , 2002, Progress in lipid research.

[21]  K. Mäder,et al.  Solid lipid nanoparticles: production, characterization and applications. , 2001, Advanced drug delivery reviews.

[22]  Kiyotaka Sato.  Crystallization behaviour of fats and lipids — a review , 2001 .

[23]  R. Müller,et al.  The role of plasma proteins in brain targeting: species dependent protein adsorption patterns on brain-specific lipid drug conjugate (LDC) nanoparticles. , 2001, International journal of pharmaceutics.

[24]  J. Kristl,et al.  Influence of spin probe structure on its distribution in SLN dispersions. , 2000, International journal of pharmaceutics.

[25]  J. Müller,et al.  Electron spin resonance investigation of electronic states in hydrogenated microcrystalline silicon , 1999 .

[26]  W Mehnert,et al.  Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[27]  Z. Zhi.  Study on the physico-chemical properties of hydroxycamptothecin-phospholipid complex , 2008 .

[28]  T. Rades,et al.  Solid Lipid Nanoparticles , 2006 .

[29]  D. Cafiso,et al.  Distribution of Phospholipids and Triglycerides in Multivesicular Lipid Particles , 1999 .